G01N 2333/745
Assays involving non-enzymic blood coagulation factors
G01N2333/745 (Assays involving non-enzymic blood coagulation factors) appears on 392 US grants and 484 published applications in this corpus.
Search patents in G01N- Granted patents
- 392
- Published applications
- 484
- Assignees
- 355
- Inventors
- 1,177
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 3 | 0 |
| 1980 | 1 | 0 |
| 1981 | 6 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 5 | 0 |
| 1988 | 6 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 9 | 0 |
| 1993 | 13 | 0 |
| 1994 | 9 | 0 |
| 1995 | 11 | 0 |
| 1996 | 12 | 0 |
| 1997 | 6 | 0 |
| 1998 | 21 | 0 |
| 1999 | 11 | 0 |
| 2000 | 13 | 0 |
| 2001 | 6 | 2 |
| 2002 | 5 | 9 |
| 2003 | 3 | 12 |
| 2004 | 3 | 10 |
| 2005 | 2 | 6 |
| 2006 | 4 | 11 |
| 2007 | 2 | 9 |
| 2008 | 2 | 10 |
| 2009 | 4 | 23 |
| 2010 | 2 | 16 |
| 2011 | 9 | 18 |
| 2012 | 9 | 16 |
| 2013 | 10 | 28 |
| 2014 | 14 | 14 |
| 2015 | 16 | 23 |
| 2016 | 10 | 30 |
| 2017 | 13 | 25 |
| 2018 | 14 | 18 |
| 2019 | 13 | 29 |
| 2020 | 16 | 23 |
| 2021 | 21 | 27 |
| 2022 | 10 | 28 |
| 2023 | 15 | 32 |
| 2024 | 12 | 28 |
| 2025 | 15 | 28 |
| 2026 | 8 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Protein biomarker indicators of neurological injury and/or disease and methods of use thereof15 Sep 2026US 12,736,547 B2Brainbox Solutions, Inc.
- Method for manufacturing microchip for blood coagulation test11 Aug 2026US 12,702,981 B2ZACROS Corporation
- FVIII inhibitor assay9 Jun 2026US 12,650,437 B2Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH
- Anti-ADAMTS13 antibody and use thereof5 May 2026US 12,617,869 B2Alfresa Pharma Corporation
- Methods of diagnosing malignant diseases5 May 2026US 12,618,841 B2St Innovative Diagnostics Ltd
- Depletion of high-abundance plasma proteins using in situ growth of metal-organic frameworks (mofs) for proteomic analysis and biomarker discovery10 Sep 2026US 2026/0266814 A1
- Protein biomarker indicators of neurological injury and/or disease and methods of use thereof10 Sep 2026US 2026/0266850 A1Brainbox Solutions, Inc.
- Luminescent detection of ADAMTS1330 Jul 2026US 2026/0218270 A1Enzyre B.V.
- Method for analyzing blood coagulation ability of blood specimen23 Jul 2026US 2026/0210982 A1Public University Corporation Nara Medical University
- Means and methods to determine cellular avidity9 Jul 2026US 2026/0194530 A1
Most cited
By later US patents
- Fluidic device for medical diagnostics220US 6,521,182 B1LifeScan, Inc. · 2003
- Initiation of an analytical measurement in blood180US 6,084,660 ALifeScan, Inc. · 2000
- Microdroplet dispensing for a medical diagnostic device157US 6,830,934 B1LifeScan, Inc. · 2004
- Method and apparatus for detection of molecular events using temperature control of detection environment127US 6,627,461 B2Signature BioScience, Inc. · 2003
- Fluidic device for medical diagnostics125US 7,022,286 B2LifeScan, Inc. · 2006